Gara Jalqabaatti › Dhibee Autoimmune
Qorannoo klinikaalii Dhibee Autoimmune Ameerikaa Keessatti hirmaatuu
Qorannoo 76 Dhibee Autoimmune f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 21
- Washington, DCQorannoo 19
- New York City, NYQorannoo 19
- Philadelphia, PAQorannoo 16
- Durham, NCQorannoo 15
- Boston, MAQorannoo 13
- Los Angeles, CAQorannoo 12
- Chicago, ILQorannoo 12
- Dallas, TXQorannoo 9
- Cleveland, OHQorannoo 8
- Atlanta, GAQorannoo 8
- Milwaukee, WIQorannoo 8
- Portland, ORQorannoo 8
- Cedar Rapids, IAQorannoo 7
- Seattle, WAQorannoo 7
- Pittsburgh, PAQorannoo 7
- Orange, CAQorannoo 7
- San Francisco, CAQorannoo 7
- Ann Arbor, MIQorannoo 6
- Memphis, TNQorannoo 6
- Salt Lake City, UTQorannoo 6
- Louisville, KYQorannoo 6
- The Bronx, NYQorannoo 6
- Jacksonville, FLQorannoo 6
- Baltimore, MDQorannoo 6
- Miami, FLQorannoo 6
- Mountain View, CAQorannoo 6
- Rochester, MNQorannoo 6
- Kansas City, KSQorannoo 6
- San Diego, CAQorannoo 5
- New Haven, CTQorannoo 5
- Nashville, TNQorannoo 5
- Sacramento, CAQorannoo 5
- Aurora, COQorannoo 5
- Phoenix, AZQorannoo 4
- St. Louis, MOQorannoo 4
- Indianapolis, INQorannoo 4
- Kansas City, MOQorannoo 4
- Greenville, NCQorannoo 4
- Orlando, FLQorannoo 4
Naannoon
- AlabamaQorannoo 5
- ArizonaQorannoo 6
- ArkansasQorannoo 3
- CaliforniaQorannoo 27
- ColoradoQorannoo 8
- ConnecticutQorannoo 5
- Distaarikii KoloombiyaaQorannoo 6
- FloridaQorannoo 20
- GeorgiaQorannoo 10
- IllinoisQorannoo 14
- IndianaQorannoo 4
- IowaQorannoo 7
- KansasQorannoo 7
- KentuckyQorannoo 8
- MarylandQorannoo 21
- MassachusettsQorannoo 16
- MichiganQorannoo 9
- MinnesotaQorannoo 9
- MissouriQorannoo 7
- NebraskaQorannoo 3
- New JerseyQorannoo 5
- New YorkQorannoo 24
- North CarolinaQorannoo 18
- OhioQorannoo 13
- OklahomaQorannoo 4
- OregonQorannoo 9
- PennsylvaniaQorannoo 21
- South CarolinaQorannoo 4
- TennesseeQorannoo 10
- TexasQorannoo 22
- UtahQorannoo 7
- VirginiaQorannoo 6
- WashingtonQorannoo 8
- WisconsinQorannoo 8
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00867269NIAID Centralized Sequencing Protocol
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
1 Day – 100 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03206099Natural History of Bronchiectasis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 5 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00943514Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06817889Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 hanga 69 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT04339777Environmental Risk Factors for the Anti-synthetase Syndrome
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 4 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT02579967Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07621809Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT04097561Secukinumab Open Label Roll-over Extension Protocol
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 6 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT04638647A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07541287Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 99 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT00001350Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Namoota walitti qabaa jiraQorannoo ilaalaa
1 Month – 100 Years · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT00246857Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT00977977Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07513181A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06722235A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 hanga 70 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07328581RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 6 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05671757METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 69 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07699380A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07059000A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07182227Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.